Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Roles of treatment initiation sites and FuFs in DR-TB management.

More »

Table 1 Expand

Fig 1.

The number of RR-TB/MDR-TB patients enrolled by year.

More »

Fig 1 Expand

Fig 2.

GeneXpert machines and DR-TB treatment sites in 2012 and 2017.

More »

Fig 2 Expand

Table 2.

Characteristics of RR-TB/MDR-TB patients enrolled for treatment in 2012 and 2017.

More »

Table 2 Expand

Table 3.

Six-month interim outcomes for RR-TB/MDR-TB patients enrolled from 2012 to 2016.

More »

Table 3 Expand

Table 4.

Twelve-month interim outcomes for RR-TB/MDR-TB patients enrolled in 2012–2015.

More »

Table 4 Expand

Table 5.

Final treatment outcomes for RR-TB/MDR-TB patients enrolled in 2012 and 2015.

More »

Table 5 Expand